HKD 14.76
(-2.25%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.1 Billion CNY | 26.56% |
2022 | 868.42 Million CNY | 39.25% |
2021 | 623.66 Million CNY | 61.84% |
2020 | 385.35 Million CNY | 51.01% |
2019 | 246.11 Million CNY | 66.24% |
2018 | 154.64 Million CNY | 89.98% |
2017 | 80.8 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 631.95 Million CNY | 0.0% |
2023 Q2 | 478.65 Million CNY | 0.0% |
2023 FY | - CNY | 26.56% |
2023 Q4 | 572.2 Million CNY | 0.0% |
2022 Q4 | 444.88 Million CNY | 0.0% |
2022 FY | - CNY | 39.25% |
2022 Q2 | 423.54 Million CNY | 0.0% |
2021 FY | - CNY | 61.84% |
2021 Q2 | 277.91 Million CNY | 0.0% |
2021 Q4 | 345.75 Million CNY | 0.0% |
2020 Q4 | 215.79 Million CNY | 0.0% |
2020 Q2 | 169.56 Million CNY | 0.0% |
2020 FY | - CNY | 51.01% |
2019 Q2 | 104.76 Million CNY | 0.0% |
2019 FY | - CNY | 66.24% |
2019 Q4 | 137.77 Million CNY | 0.0% |
2018 Q4 | 61.52 Million CNY | 0.0% |
2018 FY | - CNY | 89.98% |
2018 Q2 | 38.7 Million CNY | 0.0% |
2018 Q1 | 38.7 Million CNY | 0.0% |
2017 FY | - CNY | 0.0% |
2017 Q1 | 22.63 Million CNY | 0.0% |
2017 Q2 | 22.63 Million CNY | 0.0% |
2017 Q4 | 38.7 Million CNY | 0.0% |
2016 Q4 | 22.63 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -1511.955% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | -585.137% |
Human Health Holdings Limited | 104.06 Million HKD | -966.458% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | -279.933% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -730.619% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | -2003.565% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | 2611.369% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | -208.379% |
Town Health International Medical Group Limited | 53.5 Million HKD | -1974.352% |
Medicskin Holdings Limited | 6.77 Million HKD | -16278.38% |
Hang Chi Holdings Limited | 81.58 Million HKD | -1260.265% |